Tarsus Pharmaceuticals, Inc. · 2 days ago
Associate Director, QA (R&D)
Tarsus Pharmaceuticals, Inc. is a company focused on the pharmaceutical industry, seeking an Associate Director for R&D Quality Assurance. This role involves managing contract drug product manufacturers and ensuring compliance with quality standards through various responsibilities including vendor management and quality assurance procedures.
BiopharmaBiotechnologyLife Science
Responsibilities
Attend Project Team Meetings; collaboration with Pharmaceutical Sciences and Program Management
Participate in vendor calls
Review and approve Vendor Change Controls
Review and approve vendor documents including Master Manufacturing Records and Master Packaging/Labeling Records
Review and approve all specifications
Review/Approve Deviations/OOS
Review/Approve Test Record Form/Certificate of Analysis
Review executed manufacturing batch records and packaging/labeling batch records
Review/Complete Batch Record Review Form
Complete Final Disposition Form and issue Certificate of Compliance
Author/Revise Quality Assurance Procedures
Review and Approve Pharmaceutical Sciences SOPs
Perform audit report review of audits performed by 3rd party auditors
Attend Supplier Audits, as needed
Review proposed Quality Agreements
Qualification
Required
Bachelor's Degree plus 12+ years experience in the Pharmaceutical Industry
7+ years experience in Pharmaceutical Quality Assurance
Experience with investigations using root cause analysis, CAPA and CAPA effectiveness
Strong attention to detail
Proficient technical skills across multiple platforms
Strong knowledge of Microsoft Office Systems
Analytical skills to interpret statistical data
Benefits
Health, dental and vision insurance benefits
Generous paid time off, including vacation, holidays, and personal days
Company
Tarsus Pharmaceuticals, Inc.
Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Funding
Current Stage
Public CompanyTotal Funding
$710.6MKey Investors
Pharmakon AdvisorsVivo Capital
2025-03-12Post Ipo Equity· $125M
2024-04-19Post Ipo Debt· $75M
2024-02-29Post Ipo Equity· $100M
Leadership Team
Recent News
Tarsus Pharmaceuticals, Inc
2025-11-06
Tarsus Pharmaceuticals, Inc
2025-11-05
2025-11-05
Company data provided by crunchbase